EASL: Boceprevir Plays Well With Interferon Drugs (CME/CE)
BERLIN (MedPage Today) — Boceprevir, an investigational protease inhibitor for hepatitis C virus (HCV) infection, is effective against genotype 1 of the virus irrespective of whether it is combined with peginterferon alfa-2a or 2b.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com